An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...

Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The module <NameOfSystemFile> failed to load. Make sure the binary is sorted at the specified path or debug it to check for problems with the binary or dependent .DLL ...

Get ready for another hot day ahead for the Mid-South. highs nearing 90 and a nice breeze picking back up from the north west. Our Heat Advisory today will not be as wide spread, but caution is urged ...

Building a PC in 2026 means navigating inflated RAM, storage, and GPU prices. We assembled four balanced systems that ...

Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.

Regularly joining NHL Now will be a fresh off the ice stable of analysts. In this refreshed format, the program will take viewers inside the locker room with candid commentary on the hottest topics ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Joshua Lyon Joshua Lyon is a writer covering home and decor. He requires nine ...

If you need assistance, call the newsroom at 203-784-8801.